Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy-Reference-Cited by-全球学者库

Serum miRNA-21: Elevated levels in patients with metastatic hormone-refractory prostate cancer and potential predictive factor for the efficacy of docetaxel-based chemotherapy

Published:2010-09-14 Issue:3 Volume:71 Page:326-331
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Zhang Hai-Liang,Yang Li-Feng,Zhu Yao,Yao Xu-Dong,Zhang Shi-Lin,Dai Bo,Zhu Yi-Ping,Shen Yi-Jun,Shi Guo-Hai,Ye Ding-Wei

Publisher

Wiley

Subject

Urology,Oncology

Reference35 articles.

1. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: International comparisons;Quinn;BJU Int,2002

2. Cancer incidence and mortality in Europe 2004;Boyle;Ann Oncol,2005

3. Cancer statistics 2009;Jemal;CA Cancer J Clin,2009

4. Management of prostate cancer in China: A multicenter report of 6 institutions;Peyromaure;J Urol,2005

5. Evaluation of prostate cancer characteristics in four populations worldwide;Zeigler-Johnson;Can J Urol,2008

Cited by 274 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer;Scientific Reports;2024-01-06

2. Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells;Cell Death Discovery;2023-12-08

3. Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules;Frontiers in Genetics;2023-02-17

4. MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer;Translational Oncology;2023-02

5. Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer;Methods in Molecular Biology;2023